Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Assets AverageEnterprise ValueEquity AverageEquity RatioInterest Coverage RatioInvested CapitalReturn on AssetsReturn on Capital EmployedReturn on EquityTimes Interest Earned

Allogene Therapeutics (ALLO) Return on Invested Capital (2019 - 2020)

Allogene Therapeutics' Return on Invested Capital history spans 2 years, with the latest figure at 0.22% for Q3 2020.

  • For Q3 2020, Return on Invested Capital changed N/A year-over-year to 0.22%; the TTM value through Sep 2020 reached 0.22%, changed N/A, while the annual FY2024 figure was 0.59%, N/A changed from the prior year.
  • Return on Invested Capital for Q3 2020 was 0.22% at Allogene Therapeutics, up from 0.27% in the prior quarter.
  • Across five years, Return on Invested Capital topped out at 0.22% in Q3 2020 and bottomed at 0.36% in Q1 2020.